The global kaempferol market size was valued at USD 3.76 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 3.9% from 2022 to 2030. The demand for the product is anticipated to be driven by the increasing health and lifestyle diseases, coupled with the growing consumer awareness regarding organic and nutritional food products. Kaempferol is a flavonoid that is extracted from plants or food products. It is a natural flavonoid having low solubility in water. It is a yellow solid crystalline flavonoid that is soluble in dimethyl sulfoxide, hot ethanol, and ethers. It has a high melting point ranging from 276 to 278 °Celsius. The product is widely used as a key ingredient for the production of pharmaceutical drugs.
Kaempferol is a secondary metabolite that is found in different plants that act as an antioxidant and helps in suppressing oxidative stress. The manufacturers are extensively focusing on the research & development activities for the development of natural product alternatives. This, in turn, is likely to positively influence the market growth in the coming years.
It is often present in various natural sources such as citrus fruits, grapes, apples, onions, and red wine. Plants that contain kaempferol include aloe vera, cuscuta chinensis, glycine max, and moringa oleifera, among others. It aids in reducing oxidative damage to our DNA, cells, and lipids. It exhibits several pharmacological activities such as antimicrobial, anticancer, and antidiabetic properties.
Consumers are willing to purchase kaempferol via different retail platforms, which, in turn, helps manufacturers to further diversify their distribution channels. The dietary supplements and medicines comprising kaempferol are available at various offline as well as online stores. The offline stores include departmental stores and supermarkets that offer ease and convenience in terms of supply. In addition, the specialty stores for pharmacy drugs allow consumers to avail utility products. The diversification of distribution channels by product manufacturers is expected to fuel the global market demand over the forecast years.
98% purity kaempferol dominated the market with a revenue share of more than 60.0% in 2021. This is attributed to the growing demand for the product from the pharmaceutical industry. The rising instances of skin cancer among men and women are also influencing product demand across regions. It acts as a novel chemopreventive agent against SUV-induced skin carcinogenesis and targets MSK1 and RSK2 cells. This is driving the demand for high-quality kaempferol in the pharmaceutical industry.
Different types of medicinal drugs are manufactured using kaempferol including cancer-causing drugs, skincare ointments, and diabetic medicines. The rising demand for the product in pharmaceutical drugs can be attributed to its anti-analgesic and anti-inflammatory properties. It is also widely used in dermatological creams that act as a protector against UVB photo damage and aging in skin fibroblasts. This, in turn, is expected to significantly foster the market growth.
The 10% purity is extensively used in the food and beverage industry as it helps in averting tumor growth and cancer resulting cells. The demand for natural/organic products is rising, especially among the older population, as it targets the treatment of age-related issues such as bone and joint pain. The different food items containing kaempferol include fruits, teas, green vegetables, apricots, and berries, among others. The rising shift in the demand for natural products instead of conventional products is likely to boost product demand over the forecast period.
50% purity kaempferol is suitable for dietary supplements as it helps in treating health disorders such as weight loss/management and prevents diabetes, CVD diseases, and obesity. Commercial weight loss management chains are also advising their consumers on the consumption of these supplements to overcome weight-related issues at a global level. Thus, it is anticipated to positively influence the market growth in the coming years.
The pharmaceuticals segment dominated the market with a revenue share of over 30.0% in 2021. This is attributed to the growing use of kaempferol in the production of pharmaceutical drugs on the account of its anti-inflammatory and anti-cancer properties. It helps in lowering the prevalence of different types of cancer such as stomach, colon, bladder, skin, and liver.
Consumers have become more health-conscious, especially after the outburst of COVID-19. The global market has witnessed a drastic shift in the consumer preference for dietary supplements to maintain their health owing to the rising healthcare costs. These types of supplements offer several health benefits such as the prevention of arthritis, allergies, CVD disease, and low cholesterol at an affordable price. Such factors are expected to trigger market growth over the forecast period.
There is a growing trend in curbing obesity and weight management issues, which, in turn, is also driving the product demand in dietary supplement applications. These products are often consumed by bodybuilders and athletes to enhance their performance and improve muscle strength. However, today even a regular individual is also inclined towards the consumption of such supplements to maintain their muscle growth.
Moreover, it helps in aiding type 1 diabetes and chronic diarrhea diseases as it encompasses various micronutrients. It is also used for the treatment of different chronic diseases such as CFS, asthma, and cancer. Manufacturers are continuously focusing on R&D activities to create improvised products to enhance their utilities across the market, which is expected to trigger market growth globally.
North America dominated the market with a revenue share of over 30.0% in 2021. This is attributed to the rising awareness regarding the increased prevalence of individuals with lung, ovarian, and breast cancer. The drugs containing kaempferol have lower toxicity than the standard chemotherapy drugs. This, in turn, is driving the market demand across the region.
There is a shift in the consumer preference for organic product alternatives such as dietary supplements instead of pharmaceutical drugs across developed economies, especially in North America and Europe. Furthermore, the consumption of dietary supplements is rising among the geriatric population as they are prone to several age-related diseases such as diabetes, cancer, and joint pain. The growing usage of dietary supplements across the globe is anticipated to boost the market growth in the coming years.
The market in the Asia Pacific region is expected to grow on the account of numerous factors such as the growing demand for healthy and nutritional snacks, increasing health concerns among middle-aged individuals, changing lifestyles, and rising disposable income of consumers. In addition, the rising demand for functional beverages such as green tea, red wine, and black tea is expected to propel the market growth on the account of their ability to reduce blood sugar levels in the blood.
The market is fragmented with few manufacturers catering to the product demand. The product manufacturers are engaged in continuous R&D and geographical expansion to attain a competitive edge in the market. For instance, in August 2020, Cambridge Isotope Laboratories Inc. expanded its production capacity of a 13 C separation facility in Ohio, U.S. This expansion resulted in a 25% increase in the production level of the company.
Manufacturers are focusing intensely on improving their product portfolios, along with the introduction of natural products aimed at keeping pace with future requirements for sustainable development. Some prominent players in the global kaempferol market include:
Aktin Chemicals Inc.
FUJIFILM Wako Chemicals U.S.A Corporation
Shaanxi NHK Technology
Risun Bio-Tech
TCI Chemicals (India) Pvt. Ltd.
Spectrum Chemical Mfg. Corp.
INDOFINE Chemical Company, Inc.
Report Attribute |
Details |
Market size value in 2022 |
USD 3.86 billion |
Revenue forecast in 2030 |
USD 5.29 billion |
Growth rate |
CAGR of 3.9% from 2022 to 2030 |
Base year for estimation |
2021 |
Historical data |
2018 - 2020 |
Forecast period |
2022 - 2030 |
Quantitative units |
Revenue in USD million, volume in tons, and CAGR from 2022 to 2030 |
Report coverage |
Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Purity, application, region |
Regional scope |
North America; Europe; Asia Pacific; Central & South America; Middle East & Africa |
Country scope |
U.S.; Canada; Mexico; Germany; U.K.; France; China; India; Japan; South Korea; Brazil; Argentina; Saudi Arabia; South Africa |
Key companies profiled |
Aktin Chemicals Inc.; FUJIFILM Wako Chemicals U.S.A Corporation; TCI Chemicals (India) Pvt. Ltd.; INDOFINE Chemical Company, Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue and volume growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global kaempferol market report on the basis of purity, application, and region:
Purity Outlook (Volume, Tons; Revenue, USD Million, 2018 - 2030)
10%
20%
50%
95%
98%
Application Outlook (Volume, Tons; Revenue, USD Million, 2018 - 2030)
Food & Beverages
Cosmetics
Pharmaceuticals
Dietary Supplements
Others
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Asia Pacific
China
India
Japan
South Korea
Central & South America
Brazil
Argentina
Middle East & Africa
Saudi Arabia
South Africa
b. The global kaempferol market size was estimated at USD 3.76 billion in 2021 and is expected to reach USD 3.86 billion in 2022.
b. The global kaempferol market is expected to grow at a compound annual growth rate of 3.9% from 2022 to 2030 to reach USD 5.29 billion by 2030.
b. North America dominated the kaempferol market with a share of 34.6% in 2021. This is attributable to increasing health and lifestyle diseases coupled with the growing consumer awareness for organic and nutritional food products.
b. Some key players operating in the kaempferol market include Aktin Chemicals Inc., FUJIFILM Wako Chemicals U.S.A Corporation, TCI Chemicals (India) Pvt. Ltd, INDOFINE Chemical Company, Inc.
b. Key factors that are driving the kaempferol market growth include the growing inclusion of high-quality kaempferol in the pharmaceutical sector, a rising shift in the demand for natural products instead of conventional products, and a drastic shift in the consumer preference for dietary supplements to maintain their health owing to the rising healthcare costs.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."